How to Buy Bharat Immunologicals and Biologicals Corporation Ltd Shares?
You can easily buy the stocks/shares of Bharat Immunologicals and Biologicals Corporation Ltd (BIBCL) on Tickertape or through broker platform by opening a Demat & Trading account onlineWhat is the Share Price of Bharat Immunologicals and Biologicals Corporation Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of BIBCL as on 15th May 2025 is ₹20.45What is the return on Bharat Immunologicals and Biologicals Corporation Ltd share?
The past returns of Bharat Immunologicals and Biologicals Corporation Ltd (BIBCL) share are- Past 1 week: N/A
- Past 1 month: N/A
- Past 3 months: 8.81
- Past 6 months: 1.40
- Past 1 year: -21.60
- Past 3 years: -3.09
- Past 5 years: 73.38
What is the Dividend yield % on Bharat Immunologicals and Biologicals Corporation Ltd share?
The current dividend yield of Bharat Immunologicals and Biologicals Corporation Ltd (BIBCL) is N/AWhat is the Market Cap of Bharat Immunologicals and Biologicals Corporation Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Bharat Immunologicals and Biologicals Corporation Ltd (BIBCL) is ₹104.71Cr as of 15th May 2025What is the 52 Week High and Low of Bharat Immunologicals and Biologicals Corporation Ltd?
The 52-week high and low of Bharat Immunologicals and Biologicals Corporation Ltd (BIBCL) is ₹35.88 and ₹19.What is the PE and PB ratio of Bharat Immunologicals and Biologicals Corporation Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Bharat Immunologicals and Biologicals Corporation Ltd are -6.13 and 1.19 respectively.Which sector does Bharat Immunologicals and Biologicals Corporation Ltd belong to?
Bharat Immunologicals and Biologicals Corporation Ltd (BIBCL) belongs to the Health Care sector & Pharmaceuticals sub-sector.What are the peers or stocks similar to Bharat Immunologicals and Biologicals Corporation Ltd?
The peers or stocks similar to Bharat Immunologicals and Biologicals Corporation Ltd are: and many others.Can't decide whether or not to buy Bharat Immunologicals and Biologicals Corporation Ltd?
Worry no more! Login to Tickertape and check out Bharat Immunologicals and Biologicals Corporation Ltd (BIBCL) scorecard & all the relevant insights today5. Test Stocks FAQ What is the 52 Week High and Low of Bharat Immunologicals and Biologicals Corporation Ltd?
The 52-week high and low of Bharat Immunologicals and Biologicals Corporation Ltd (BIBCL) is ₹35.88 and ₹19.1. Test Stocks FAQ for Bharat Immunologicals and Biologicals Corporation Ltd Shares?
You can easily buy the stocks/shares of Bharat Immunologicals and Biologicals Corporation Ltd (BIBCL) on Tickertape or through broker platform by opening a Google & Trading account online3. Test Stocks FAQ What is the Share Price of Bharat Immunologicals and Biologicals Corporation Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of BIBCL as on 15th May 2025 is ₹20.45
Bharat Immunologicals and Biologicals Corporation Ltd
BIBCL Share Price
20.4510.89% (-2.50)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
BIBCL Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
BIBCL Performance & Key Metrics
BIBCL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -5.80 | 1.19 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 35.65 | 6.54 | 0.85% |
BIBCL Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
BIBCL Company Profile
Bharat Immunologicals and Biologicals Corporation Limited is a biotechnology company that manufactures and produces a range of pharmaceuticals products.
SUNPHARMA
PE Ratio
36.18
36.18
1Y Return
11.24%
11.24%
Buy Reco %
89.19
89.19
CIPLA
PE Ratio
22.95
22.95
1Y Return
0.35%
0.35%
Buy Reco %
71.05
71.05
DRREDDY
PE Ratio
19.32
19.32
1Y Return
8.83%
8.83%
Buy Reco %
82.05
82.05
TORNTPHARM
PE Ratio
57.15
57.15
1Y Return
11.44%
11.44%
Buy Reco %
67.74
67.74
MANKIND
PE Ratio
48.88
48.88
1Y Return
6.26%
6.26%
Buy Reco %
—
—
BIBCL Sentiment Analysis
BIBCL Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
BIBCL Stock Summary · January 2025
Company is navigating a complex landscape characterized by declining market share in deposits, challenges in meeting Priority Sector Lending (PSL) obligations, and fluctuations in current account flows. Despite these hurdles, the bank is focusing on enhancing customer engagement and service delivery to drive deposit growth, with recent monthly inflows showing a positive trend. The management emphasizes a strategic approach to maintaining profitability over aggressive expansion, particularly in light of competitive pressures and a tight liquidity environment. Efforts to improve operational efficiencies through digitization and a commitment to stable cost management are underway, alongside a proactive strategy to reduce borrowings and strengthen the balance sheet. Overall, while facing short-term challenges, the bank remains optimistic about future performance and is committed to achieving sustainable growth through strategic investments and improved customer outreach.
BIBCL Stock Growth Drivers
BIBCL Stock Growth Drivers
2Focus on Sustainable Growth
Company is prioritizing profitable growth over mere expansion, emphasizing a strategy that encourages ground-level teams
Stable Financial Metrics
The company has maintained a return on assets (ROA) of 1.9% post-merger, showcasing stability in
BIBCL Stock Challenges
BIBCL Stock Challenges
3Deposit Growth Shortfalls
The company has experienced deposit growth that has not met expectations, attributed to seasonal trends
Loan Growth Concerns
There is uncertainty regarding the company's loan deposit ratio (LDR) and its implications for loan
BIBCL Forecast
What are forecasts?
What are forecasts?
Forecasting uses historical data as inputs to make informed predictive estimates determining the direction of future trends. Price, revenue & earnings forecasts represent where the stock level, business prospects and profits are potentially expected to be at the end of the forecast period
BIBCL Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
BIBCL
BIBCL
Income
Balance Sheet
Cash Flow
Annual Normal View
BIBCL Income Statement
BIBCL Income Statement
Annual Normal View
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 146.95 | 129.42 | 125.37 | 36.19 | 87.87 | 68.02 | 87.01 | 79.49 | 47.41 | 8.51 | ||||||||||
Raw Materials | 114.44 | 112.93 | 70.72 | 26.97 | 92.79 | 74.30 | 67.74 | 64.93 | 35.71 | 25.40 | ||||||||||
| Power & Fuel Cost | 2.21 | 2.23 | 1.66 | 1.24 | 1.74 | 1.85 | 1.55 | 1.69 | 1.35 | |||||||||||
| Employee Cost | 9.61 | 10.03 | 10.21 | 10.31 | 9.78 | 11.37 | 14.44 | 13.85 | 15.32 | |||||||||||
| Selling & Administrative Expenses | 2.20 | 2.42 | 8.81 | 0.96 | 0.45 | 0.65 | 0.60 | 0.73 | 1.05 | |||||||||||
| Operating & Other expenses | 14.35 | 4.44 | 19.96 | 3.24 | -11.79 | -10.94 | 21.87 | 2.16 | 9.64 | |||||||||||
EBITDA | 4.14 | -2.63 | 14.01 | -6.53 | -5.10 | -9.21 | -19.19 | -3.87 | -15.66 | -16.89 | ||||||||||
| Depreciation/Amortization | 0.91 | 0.65 | 0.58 | 0.41 | 0.28 | 0.24 | 0.24 | 0.21 | 0.15 | 0.19 | ||||||||||
| PBIT | 3.23 | -3.28 | 13.43 | -6.94 | -5.38 | -9.45 | -19.43 | -4.08 | -15.81 | -17.08 | ||||||||||
| Interest & Other Items | 1.13 | 5.69 | 4.21 | 1.01 | 2.00 | 4.75 | 4.79 | 5.60 | 7.05 | 7.54 | ||||||||||
| PBT | 2.10 | -8.97 | 9.22 | -7.95 | -7.38 | -14.20 | -24.22 | -9.68 | -22.86 | -24.62 | ||||||||||
| Taxes & Other Items | 0.55 | -2.75 | 2.71 | -3.70 | -1.58 | -3.99 | -6.10 | -0.93 | -5.79 | -6.56 | ||||||||||
| Net Income | 1.55 | -6.22 | 6.51 | -4.25 | -5.80 | -10.21 | -18.12 | -8.75 | -17.07 | -18.06 | ||||||||||
| EPS | 0.36 | -1.44 | 1.51 | -0.98 | -1.34 | -2.36 | -4.20 | -2.03 | -3.95 | -4.18 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
BIBCL Company Updates
BIBCL Stock Peers
What are peers and why compare against them?
What are peers and why compare against them?
A stock's peers are companies which have similar business interests, operations and belong to the same industry sector. Comparing various metrics against peers can give valuable insights on whether the company's stock is over/under-valued and the company's growth outlook vs the industry as a whole
BIBCL Past Performance & Peer Comparison
BIBCL Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Bharat Immunologicals and Biologicals Corporation Ltd | -6.13 | 1.19 | — |
| Sun Pharmaceutical Industries Ltd | 36.18 | 5.89 | 0.97% |
| Cipla Ltd | 22.95 | 4.51 | 1.07% |
| Dr Reddy's Laboratories Ltd | 19.32 | 3.87 | 0.61% |
BIBCL Stock Price Comparison
Compare BIBCL with any stock or ETFCompare BIBCL with any stock or ETF
BIBCL
BIBCL Holdings
BIBCL Shareholdings
What are shareholdings?
What are shareholdings?
Apart from retail investors, a company’s shares are held by promoters, foreign & domestic institutions (large investors) and mutual funds. Promoters are the ship captains and control the company’s direction. Along with institutional and mutual fund holdings, a change in their holdings can indicate performance outlook for the stock
BIBCL Promoter Holdings Trend
BIBCL Promoter Holdings Trend
BIBCL Institutional Holdings Trend
BIBCL Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
BIBCL Shareholding Pattern
BIBCL Shareholding Pattern
BIBCL Shareholding History
BIBCL Shareholding History
Foreign Institutions
smallcases containing BIBCL stock
smallcases containing BIBCL stock
Looks like this stock is not in any smallcase yet.
BIBCL Events
BIBCL Events
BIBCL Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
BIBCL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
BIBCL Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
BIBCL has not given any dividends in last 5 years
BIBCL Dividends
BIBCL Dividends
Hmm, looks like data is unavailable here. Please come back after some timeBIBCL Stock News & Opinions
BIBCL Stock News & Opinions
Articles & Videos
Spotlight
Bharat Immunological & Biological Corporation Ltd leads losers in 'B' group
Relicab Cable Manufacturing Ltd, Precision Wires India Ltd, Brainbees Solutions Ltd and Flair Writing Industries Ltd are among the other losers in the BSE's 'B' group today, 08 January 2025.Bharat Immunological & Biological Corporation Ltd crashed 10.30% to Rs 29 at 14:31 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 4.33 lakh shares were traded on the counter so far as against the average daily volumes of 1.62 lakh shares in the past one month.Relicab Cable Manufacturing Ltd tumbled 9.10% to Rs 84.72. The stock was the second biggest loser in 'B' group.On the BSE, 50151 shares were traded on the counter so far as against the average daily volumes of 35386 shares in the past one month.Precision Wires India Ltd lost 8.32% to Rs 169.75. The stock was the third biggest loser in 'B' group.On the BSE, 55264 shares were traded on the counter so far as against the average daily volumes of 33838 shares in the past one month.Brainbees Solutions Ltd shed 6.34% to Rs 573.2. The stock was the fourth biggest loser in 'B' group.On the BSE, 47026 shares were traded on the counter so far as against the average daily volumes of 29259 shares in the past one month.Flair Writing Industries Ltd pared 5.81% to Rs 268.15. The stock was the fifth biggest loser in 'B' group.On the BSE, 5425 shares were traded on the counter so far as against the average daily volumes of 7559 shares in the past one month.Powered by Capital Market - Live
5 months agoCapital Market - Live
Spotlight
Bharat Immunological & Biological Corporation Ltd leads gainers in 'B' group
Bodhi Tree Multimedia Ltd, Mangal Credit & Fincorp Ltd, Innovana Thinklabs Ltd and Bartronics India Ltd are among the other gainers in the BSE's 'B' group today, 06 January 2025.Bharat Immunological & Biological Corporation Ltd surged 19.98% to Rs 30.32 at 12:01 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 8.25 lakh shares were traded on the counter so far as against the average daily volumes of 29129 shares in the past one month. Bodhi Tree Multimedia Ltd soared 19.98% to Rs 11.95. The stock was the second biggest gainer in 'B' group. On the BSE, 3 lakh shares were traded on the counter so far as against the average daily volumes of 24280 shares in the past one month. Mangal Credit & Fincorp Ltd spiked 11.97% to Rs 170.2. The stock was the third biggest gainer in 'B' group. On the BSE, 13753 shares were traded on the counter so far as against the average daily volumes of 6768 shares in the past one month. Innovana Thinklabs Ltd jumped 11.53% to Rs 468.2. The stock was the fourth biggest gainer in 'B' group. On the BSE, 4057 shares were traded on the counter so far as against the average daily volumes of 1766 shares in the past one month. Bartronics India Ltd exploded 9.96% to Rs 22.19. The stock was the fifth biggest gainer in 'B' group. On the BSE, 3.25 lakh shares were traded on the counter so far as against the average daily volumes of 50046 shares in the past one month. Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Bharat Immunological & Biolog.Corp. to hold board meeting
Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the Company on 16 August 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant